title: Multidisciplinary approach in pregnancy-associated thrombotic thrombocytopenic purpura: a case report.
authors.affiliation: Service of Immunohaematology and Transfusion Medicine, United Hospitals of Palermo, Palermo, Italy.
authors.forename: Gaetano
authors.initials: G
authors.lastname: Lucania
authors.affiliation: Service of Immunohaematology and Transfusion Medicine, United Hospitals of Palermo, Palermo, Italy.
authors.forename: Emanuele
authors.initials: E
authors.lastname: Camiolo
authors.affiliation: Department of Cardiology, United Hospitals of Palermo, Palermo, Italy.
authors.forename: Maria G
authors.initials: MG
authors.lastname: Carmina
authors.affiliation: Service of Immunohaematology and Transfusion Medicine, United Hospitals of Palermo, Palermo, Italy.
authors.forename: Teresa
authors.initials: T
authors.lastname: Fiandaca
authors.affiliation: Haematology Department, United Hospitals of Palermo, Palermo, Italy.
authors.forename: Alessandro
authors.initials: A
authors.lastname: Indovina
authors.affiliation: Haematology Department, United Hospitals of Palermo, Palermo, Italy.
authors.forename: Alessandra
authors.initials: A
authors.lastname: Malato
authors.affiliation: Service of Immunohaematology and Transfusion Medicine, United Hospitals of Palermo, Palermo, Italy.
authors.forename: Renato
authors.initials: R
authors.lastname: Messina
authors.affiliation: Haematology Department, United Hospitals of Palermo, Palermo, Italy.
authors.forename: Francesco
authors.initials: F
authors.lastname: Fabbiano
authors.affiliation: Service of Immunohaematology and Transfusion Medicine, United Hospitals of Palermo, Palermo, Italy.
authors.forename: Raimondo
authors.initials: R
authors.lastname: Marcenò
mesh_terms: D000328:Adult; D058846:Antibodies, Monoclonal, Murine-Derived / Q000009:adverse effects / Q000627:therapeutic use; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use; D002585:Cesarean Section; D003131:Combined Modality Therapy; D017984:Enoxaparin / Q000627:therapeutic use; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced; D006493:Heparin / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007231:Infant, Newborn; D033183:Interdisciplinary Communication; D007819:Laryngeal Edema / Q000139:chemically induced; D008775:Methylprednisolone / Q000627:therapeutic use; D010348:Patient Care Team; D010951:Plasma Exchange; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000188:drug therapy / Q000628:therapy*; D011644:Puerperal Disorders / Q000188:drug therapy / Q000209:etiology / Q000628:therapy; D011655:Pulmonary Embolism / Q000188:drug therapy / Q000209:etiology / Q000628:therapy; D011697:Purpura, Thrombotic Thrombocytopenic / Q000150:complications / Q000188:drug therapy / Q000628:therapy*; D012008:Recurrence; D000069283:Rituximab; D014859:Warfarin / Q000627:therapeutic use
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000925:Anticoagulants; D017984:Enoxaparin; D000069283:Rituximab; D014859:Warfarin; D006493:Heparin; D008775:Methylprednisolone